secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001104659-25-086392
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical names Thomas P. Mullin CEO; David Chernow becomes Vice Chairman
------------------------------------------------------------------------------

- Mullin, 41, promoted from Co-President, effective Sept 1, 2025; Chernow (CEO since 2014) becomes Vice Chairman.
- John A. Saich becomes sole President (was Co-President); retains oversight of outpatient rehab and shared services.
- John F. Duggan appointed EVP, General Counsel and Secretary; Michael Tarvin transitions to senior EVP of legal services.
- Mullin joined Select Medical in 2008, most recently oversaw 140 critical illness recovery and inpatient rehab hospitals.
- All changes effective immediately; company cites internal succession planning with long-tenured leaders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465925086392/0001104659-25-086392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465925086392/tm2524778d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-086392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer